Cargando…
Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1
BACKGROUND: Hyperinsulinism/hyperammonemia (HI/HA) syndrome is the second most common type of congenital hyperinsulinism caused by an activating GLUD1 mutation. OBJECTIVE: The aim of this study was to determine the clinical profile and long-term neurological outcomes in children with HI/HA syndrome....
Autores principales: | Aftab, Sommayya, Gubaeva, Diliara, Houghton, Jayne A L, Dastamani, Antonia, Sotiridou, Ellada, Gilbert, Clare, Flanagan, Sarah E, Tiulpakov, Anatoly, Melikyan, Maria, Shah, Pratik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077222/ https://www.ncbi.nlm.nih.gov/pubmed/35951311 http://dx.doi.org/10.1530/EC-22-0008 |
Ejemplares similares
-
Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1
por: Sotiridou, Ellada, et al.
Publicado: (2021) -
Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome
por: Boodhansingh, Kara E., et al.
Publicado: (2022) -
Variation in Glycemic Outcomes in Focal Forms of Congenital Hyperinsulinism—The UK Perspective
por: Dastamani, Antonia, et al.
Publicado: (2022) -
Hyperinsulinism–hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype–phenotype correlations
por: Kapoor, Ritika R, et al.
Publicado: (2009) -
Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation
por: Kiff, Sarah, et al.
Publicado: (2019)